tiprankstipranks
Trending News
More News >
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market

Takeda Pharmaceutical Co (4502) Income Statement

Compare
5 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q4 2024), Takeda Pharmaceutical Co's total revenue was ¥1.05T, an increase of 0.24% from the same quarter last year. In Q4, Takeda Pharmaceutical Co's net income was ¥-103.16B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit
¥ 2.36T¥ 2.83T¥ 2.78T¥ 2.46T¥ 2.20T
Operating Expenses
¥ 1.83T¥ 2.62T¥ 2.29T¥ 2.00T¥ 1.69T
Depreciation and Amortization
¥ 761.40B¥ 728.00B¥ 664.40B¥ 583.15B¥ 559.67B
EBITDA
¥ 1.15T¥ 874.60B¥ 1.18T¥ 1.18T¥ 983.72B
Operating Income
¥ 523.11B¥ 214.07B¥ 490.50B¥ 460.84B¥ 509.27B
Other Income/Expenses
¥ -344.04B¥ -161.28B¥ -115.42B¥ -158.27B¥ -143.03B
Pretax Income
¥ 179.07B¥ 52.79B¥ 375.09B¥ 302.57B¥ 366.24B
Net Income
¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Per Share Metrics
Basic EPS
¥ 68.36¥ 92.09¥ 204.29¥ 147.14¥ 240.72
Diluted EPS
¥ 67.23¥ 91.16¥ 201.94¥ 145.87¥ 238.96
Weighted Average Shares Outstanding
1.58B 1.56B 1.55B 1.56B 1.56B
Weighted Average Shares Outstanding (Diluted)
1.61B 1.58B 1.57B 1.58B 1.57B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis